Cargando…
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer
Prostate cancer is one of the few malignancies that includes vaccination as a treatment modality. Elements of an effective cancer vaccine should include the ability to elicit a Type I T-cell response and target multiple antigenic proteins expressed early in the disease. Using existing gene datasets...
Autores principales: | Cecil, Denise L., Curtis, Benjamin, Gad, Ekram, Gormley, Michael, Timms, Andrew E., Corulli, Lauren, Bos, Rinke, Damle, Rajendra N., Sepulveda, Manuel A., Disis, Mary L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365795/ https://www.ncbi.nlm.nih.gov/pubmed/35948756 http://dx.doi.org/10.1038/s41598-022-17950-1 |
Ejemplares similares
-
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
por: Corulli, Lauren R., et al.
Publicado: (2021) -
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways
por: Cecil, Denise, et al.
Publicado: (2021) -
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer
por: Liao, John B, et al.
Publicado: (2015) -
Optimizing the cryopreservation of murine splenocytes for improved antigen-specific T cell function in ELISPOT
por: Gad, Ekram, et al.
Publicado: (2013) -
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Stanton, Sasha E., et al.
Publicado: (2021)